Straits Times Index
3,348.87 +12.28 (+0.37%) S&P 500
5,288.59 +11.08 (+0.21%) Dow
38,593.21 -93.11 (-0.24%) Nasdaq
16,844.62 +109.60 (+0.65%) Bitcoin USD
69,809.41 +1,698.02 (+2.49%) CMC Crypto 200
1,505.70 +37.77 (+2.57%)
MDxHealth SA (MDXH)
| Previous close | 2.7500 |
| Open | 2.8000 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 2.7500 - 2.8000 |
| 52-week range | 0.3500 - 4.6400 |
| Volume | |
| Avg. volume | 68,684 |
| Market cap | 75.318M |
| Beta (5Y monthly) | -370,445.47 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.4300 |
| Earnings date | 21 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 8.80 |
GlobeNewswireMdxhealth to Present at Upcoming Investor Conferences
Mdxhealth to Present at Upcoming Investor Conferences IRVINE, CA, and HERSTAL, BELGIUM – May 15, 2024 (GlobeNewswire) – Mdxhealth SA (Nasdaq: MDXH), a commercial-stage precision diagnostics company, today announced that Michael K. McGarrity, Chief Executive Officer, will participate in the following investor conferences in June 2024. William Blair 44th Annual Growth Stock ConferencePresentation: Wednesday, June 5, at 5:00pm ETWebcast: https://wsw.com/webcast/blair97/mdxh/1942906 Jefferies Global
Insider MonkeyMDxHealth SA (NASDAQ:MDXH) Q1 2024 Earnings Call Transcript
MDxHealth SA (NASDAQ:MDXH) Q1 2024 Earnings Call Transcript May 4, 2024 MDxHealth SA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies and gentlemen, and welcome to the MDxHealth First Quarter 2024 Earnings Call. At this time, all […]
- GlobeNewswire
MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed
MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed Year-over-year Q1 revenues increase by 35% to $19.8 millionIncreasing 2024 revenue guidance to $83-85 million, previously $79-81 million Conference call with Q&A today at 08:30 AM ET / 14:30 CET IRVINE, CA, and HERSTAL, BELGIUM – May 1, 2024 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a commercial-stage precision diagnostics company, today announced its financial results for the first qu
